More evidence on association of ctDNA reduction and OS presented at AACR
Immunocore presented four posters at AACR 2023, highlighting the association between early ctDNA reduction and longer overall survival. The company showed that in the phase 3 study of KIMMTRAK (currently approved in HLA-A*02:01+ mUM) 88% of treated 1L mUM patients achieved ctDNA reduction by week n
Since 1996, Bryan, Garnier & Co has been growing with an absolute conviction that the investment banking landscape would experience a major revolution: most of the large local generalist banking groups will disappear to the benefit of a handful of global powerhouses, and an emerging group of independent, highly specialised boutique investment banks.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.